BLLN

BillionToOne (BLLN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BillionToOne’s updated analyst narrative now centers on a fresh Fair Value price target of US$128.57, compared with the prior US$122.14 level in this framework.

BillionToOne has delivered a strong year to date gain, which puts fresh focus on whether the current share price lines up with the cash the business is expected to generate over time.

Key TakeawaysNo-Headline Rally: BillionToOne stock jumped 12% to $116 on Tuesday, September 22, without a company release, stretching a run that began near $100 on September 14. Insiders Took Profits: The CEO and general counsel sold ~60K shares for ~$6.

John Roderick Ten Bosch sold shares on Sept. 9, maintaining a direct stake worth ~$2.4 million.

The medical diagnostics company disclosed a substantial insider stock sale.

MENLO PARK, Calif., Sept. 2, 2026 /PRNewswire/ -- BillionToOne, Inc.